Because patients do not always associate their symptoms with dry eye, they often turn to treatments that do not work, says Nicole Bajic, MD.

Shares of Krystal Biotech KRYS gained 3.9% yesterday after the company announced that it had dosed the first patient in a phase I/II study evaluating its eye drop KB801 for the treatment of ...

Keep Reading Zimra sabotaging ZiG, says MP RBZ reports drop in inflation The bank said payments for the same period totalled US$4,89 billion, resulting in a favourable balance of payments position.

PITTSBURGH - Krystal Biotech, Inc. (NASDAQ:KRYS), a $4.1 billion biotech company with impressive 93% gross profit margins according to InvestingPro data, has dosed the first patient in its Phase 1/2 ...

Krystal Biotech begins phase 1/2 trial of eye drop gene therapy for NK Company News Published 07/09/2025, 07:19 AM 0 ...

Nearly 30% of Americans experience eye symptoms caused by allergens—and that number could grow in coming years due to climate change, as experts warn changing weather patterns “may increase pollen ...

ESPN analyst Brian Windhorst shared his thoughts on what the future might hold for Anthony Edwards and the Minnesota Timberwolves.

2025 NBA Draft team grades: Cooper Flagg earns an easy 'A+' for Mavericks; Nets drop ball despite five picks The NBA Draft is over for another year and here's an early look at how each team did ...

Colorado communities rely on tourism to keep their coffers full, but there’s some sign that fewer people are coming to the state to visit — and spend money.

Opus Genetics' eye drop shows promise for age-related vision loss in Phase 3 trial. Company plans FDA filing to expand medication's approved uses.

Marcy L. Oglesby was found guilty of first-degree murder, attempted murder and aggravated battery in connection with the death of former police chief Richard Young, and now faces a sentence of at l… ...